ASX - By Stock
|
M2R |
Re:
Ann: Gold & Nickel Exploration Update
|
|
88888acct
|
10 |
2.8K |
6 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
10
|
2.8K
|
6
|
|
ASX - By Stock
|
EE1 |
Re:
Ann: Re-listing Presentation
|
|
88888acct
|
4 |
1.4K |
4 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
4
|
1.4K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Proposed issue of securities - RHY
|
|
88888acct
|
31 |
10K |
3 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
31
|
10K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Trading Halt
|
|
88888acct
|
29 |
9.4K |
2 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
29
|
9.4K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Proposed issue of securities - RHY
|
|
88888acct
|
31 |
10K |
4 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
31
|
10K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Trading Halt
|
|
88888acct
|
29 |
9.4K |
7 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
29
|
9.4K
|
7
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Trading Halt
|
|
88888acct
|
29 |
9.4K |
4 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
29
|
9.4K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Why has Rhythm soared tfr on 11 cents to 15 cents in 4 trading sessions?
|
|
88888acct
|
8 |
2.8K |
2 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
8
|
2.8K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
2 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
91
|
29K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
4 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
91
|
29K
|
4
|
|
ASX - By Stock
|
RHY Biotech |
Re:
Rhy: Proxy forms.
|
|
88888acct
|
29 |
8.2K |
3 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
29
|
8.2K
|
3
|
|
ASX - By Stock
|
RHY Biotech |
Re:
Rhy: Proxy forms.
|
|
88888acct
|
29 |
8.2K |
3 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
29
|
8.2K
|
3
|
|
ASX - By Stock
|
RHY Biotech |
Re:
Rhy: Proxy forms.
|
|
88888acct
|
29 |
8.2K |
3 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
29
|
8.2K
|
3
|
|
ASX - By Stock
|
RHY Biotech |
Re:
Rhy: Proxy forms.
|
|
88888acct
|
29 |
8.2K |
5 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
29
|
8.2K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
3 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
91
|
29K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
2 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
91
|
29K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
3 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
91
|
29K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
5 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
91
|
29K
|
5
|
|
ASX - By Stock
|
RHY Biotech |
Re:
Rhy: Proxy forms.
|
|
88888acct
|
29 |
8.2K |
7 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
29
|
8.2K
|
7
|
|
ASX - By Stock
|
RHY Biotech |
Re:
Rhy: Proxy forms.
|
|
88888acct
|
29 |
8.2K |
6 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
29
|
8.2K
|
6
|
|
ASX - By Stock
|
RHY Biotech |
Re:
Rhy: Proxy forms.
|
|
88888acct
|
29 |
8.2K |
5 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
29
|
8.2K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
2 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
91
|
29K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
1 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
91
|
29K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
0 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
91
|
29K
|
0
|
|
ASX - By Stock
|
RHY Biotech |
Re:
Rhy: Proxy forms.
|
|
88888acct
|
29 |
8.2K |
6 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
29
|
8.2K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
3 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
91
|
29K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
7 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
91
|
29K
|
7
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
88888acct
|
91 |
29K |
11 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
91
|
29K
|
11
|
|
ASX - By Stock
|
BTE Energy |
Event: listing on the Botswana Stock Exchange (BSE) yesterday.
|
|
88888acct
|
0 |
358 |
4 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
0
|
358
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix confirms Phase 3 study design appropriate for China
|
|
88888acct
|
44 |
19K |
19 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
44
|
19K
|
19
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix confirms Phase 3 study design appropriate for China
|
|
88888acct
|
44 |
19K |
17 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
44
|
19K
|
17
|
|
ASX - By Stock
|
FRS |
Re:
Ann: 63m pegmatite intersected at maiden Calypso drilling-Updated
|
|
88888acct
|
98 |
40K |
2 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
98
|
40K
|
2
|
|
ASX - By Stock
|
RAD |
Re:
Jones Research updated with price target of $0.75
|
|
88888acct
|
8 |
4.4K |
3 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
8
|
4.4K
|
3
|
|
ASX - By Stock
|
RAD |
Jones Research updated with price target of $0.75
|
|
88888acct
|
8 |
4.4K |
8 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
8
|
4.4K
|
8
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
88888acct
|
171 |
66K |
6 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
171
|
66K
|
6
|
|
ASX - By Stock
|
RAD |
Re:
Ann: FDA Pre-IND meeting supports an IND application for RAD 101
|
|
88888acct
|
13 |
4.1K |
23 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
13
|
4.1K
|
23
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
88888acct
|
73 |
23K |
7 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
73
|
23K
|
7
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
88888acct
|
73 |
23K |
6 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
73
|
23K
|
6
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
88888acct
|
171 |
66K |
3 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
171
|
66K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD to present at virtual healthcare conference
|
|
88888acct
|
85 |
24K |
6 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
85
|
24K
|
6
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD to present at virtual healthcare conference
|
|
88888acct
|
85 |
24K |
1 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
85
|
24K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD to present at virtual healthcare conference
|
|
88888acct
|
85 |
24K |
10 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
85
|
24K
|
10
|
|
ASX - By Stock
|
RNX |
Re:
Ann: Investor Presentation
|
|
88888acct
|
10 |
5.3K |
5 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
10
|
5.3K
|
5
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm Theranostics initiates process for Nasdaq listing
|
|
88888acct
|
50 |
20K |
9 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
50
|
20K
|
9
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm Theranostics initiates process for Nasdaq listing
|
|
88888acct
|
50 |
20K |
5 |
18/02/23 |
18/02/23 |
ASX - By Stock
|
50
|
20K
|
5
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm Theranostics initiates process for Nasdaq listing
|
|
88888acct
|
50 |
20K |
17 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
50
|
20K
|
17
|
|
ASX - By Stock
|
RAD |
Re:
Ann: aVb6 Integrin (RAD301) IND approval for Phase 1 trial
|
|
88888acct
|
18 |
8.8K |
6 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
18
|
8.8K
|
6
|
|
ASX - By Stock
|
RAD |
Re:
Ann: aVb6 Integrin (RAD301) IND approval for Phase 1 trial
|
|
88888acct
|
18 |
8.8K |
18 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
18
|
8.8K
|
18
|
|
ASX - By Stock
|
RAD |
Re:
Ann: aVb6 Integrin (RAD301) IND approval for Phase 1 trial
|
|
88888acct
|
18 |
8.8K |
15 |
31/12/22 |
31/12/22 |
ASX - By Stock
|
18
|
8.8K
|
15
|
|
ASX - By Stock
|
RAD |
Re:
Bell Potter Healthcare Conference 2022
|
|
88888acct
|
25 |
11K |
1 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
25
|
11K
|
1
|
|